1. PubChem Compound Summary for CID 10130337, Solriamfetol;National Center for Biotechnology Information;PubChem,2022
2. PubChem Compound Summary for CID 9948102, Pitolisant;National Center for Biotechnology Information;PubChem,2022
3. Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients;Evans;Proc. Natl. Acad. Sci. U. S. A.,2022
4. The Voice of the Patient: Narcolepsy;Center for Drug Evaluation and Research,2014
5. Listening to the patient voice in narcolepsy: diagnostic delay, disease burden, and treatment efficacy;Maski;J. Clin. Sleep Med.,2017